Ovarian function following a single administration of depomedroxyprogesterone acetate (DMPA) at different doses
- 1 August 1984
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 42 (2) , 216-222
- https://doi.org/10.1016/s0015-0282(16)48016-7
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Interaction of medroxyprogesterone acetate with cytosol androgen receptors in the rat hypothalamus and pituitaryThe Journal of Steroid Biochemistry and Molecular Biology, 1983
- On the mechanism of action of progestinsActa Endocrinologica, 1981
- Pharmacokinetic study of different doses of Depo ProveraContraception, 1980
- Plasma levels and pharmacokinetics of ethynyl estrogens in various populationsContraception, 1980
- A radioimmunoassay for serum medroxyprogesterone acetateThe Journal of Steroid Biochemistry and Molecular Biology, 1978
- Serum Medroxyprogesterone Acetate (MPA) Concentrations and Ovarian Function Following Intramuscular Injection of Depo-MPAJournal of Clinical Endocrinology & Metabolism, 1977
- Medroxyprogesterone acetate, estradiol, FSH and LH in peripheral blood after intramuscular administration of depo-provera® to womenContraception, 1976
- Effects of 0.5 mg. of lynestrenol daily on hypothalamic-pituitary-ovarian functionAmerican Journal of Obstetrics and Gynecology, 1975
- A cross-sectional study of plasma FSH and LH levels in women using sequential, combination or injectable steroid contraceptives over long periods of timeContraception, 1970
- CONCEPTION CONTROL BY MONTHLY INJECTIONS OF MEDROXYPROGESTERONE SUSPENSION AND A LONG-ACTING OESTROGENReproduction, 1968